• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩展格雷夫斯三联征:甲状腺眼病、皮肤病变和杵状指:对替普罗单抗的临床反应

Extending the Graves' Triad: Thyroid Eye Disease, Dermopathy, and Acropachy: A Clinical Response to Teprotumumab.

作者信息

Lira Javier, Dixon Paige, Zaidi Mone, Kim Se-Min

机构信息

Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

Center for Translational Medicine and Pharmacology, Department of Pharmacological Science, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.

出版信息

JCEM Case Rep. 2025 Aug 13;3(9):luaf156. doi: 10.1210/jcemcr/luaf156. eCollection 2025 Sep.

DOI:10.1210/jcemcr/luaf156
PMID:40808980
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12344415/
Abstract

Thyroid acropachy is a rare extrathyroidal manifestation of Graves' disease. Due to a limited understanding of the pathophysiology, no specific treatment exists. Here we discuss such a case and its response to treatment. A 25-year-old male with Graves' disease, for which he had total thyroidectomy 2 years previously, presented with worsening double vision. He also reported swelling in legs, as well as pain and stiffness in his hands and feet. Physical examination revealed bilateral asymmetric proptosis and plaque-like lesions with nonpitting edema on the pretibial skin. Fusiform swelling of the fingers and clubbing of the fingernails and toenails were also noted. Laboratory findings showed elevated thyrotropin-receptor antibodies of 81.1 IU/L (0.0-1.75). He was euthyroid with levothyroxine supplementation. Bilateral hand X-rays noted soft tissue swelling and bilateral periostitis and subperiosteal bone formation. Teprotumumab was initiated for Graves' ophthalmopathy, which improved his proptosis and orbital inflammation. Notably, the patient's pretibial myxedema, along with swelling in the bilateral metacarpals and phalanges, also improved. This case is the first to demonstrate clinical improvement in thyroid acropachy following teprotumumab. This observation suggests that pathophysiology of thyroid acropachy may involve interplay between the TSH receptor and IGF-1 receptor signaling, similar to the ophthalmopathy.

摘要

甲状腺性杵状指(趾)是格雷夫斯病一种罕见的甲状腺外表现。由于对其病理生理学的了解有限,目前尚无特效治疗方法。在此,我们讨论这样一个病例及其治疗反应。一名25岁男性,患有格雷夫斯病,2年前已行甲状腺全切除术,现出现复视加重。他还报告腿部肿胀,以及手脚疼痛和僵硬。体格检查发现双侧不对称突眼,胫前皮肤有斑块样病变伴非凹陷性水肿。还注意到手指呈梭形肿胀,指甲和趾甲杵状变。实验室检查结果显示促甲状腺素受体抗体升高至81.1 IU/L(0.0 - 1.75)。他在补充左甲状腺素的情况下甲状腺功能正常。双手X线检查显示软组织肿胀、双侧骨膜炎和骨膜下骨形成。开始使用替普罗单抗治疗格雷夫斯眼病,这改善了他的突眼和眼眶炎症。值得注意的是,患者的胫前黏液性水肿以及双侧掌骨和指骨肿胀也有所改善。该病例是首例显示替普罗单抗治疗后甲状腺性杵状指(趾)有临床改善的病例。这一观察结果表明,甲状腺性杵状指(趾)的病理生理学可能涉及促甲状腺激素受体和胰岛素样生长因子-1受体信号之间的相互作用,类似于眼病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c51/12344415/1e1a42748888/luaf156f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c51/12344415/e903b0b9e7ab/luaf156f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c51/12344415/423fa679c59c/luaf156f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c51/12344415/1e1a42748888/luaf156f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c51/12344415/e903b0b9e7ab/luaf156f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c51/12344415/423fa679c59c/luaf156f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c51/12344415/1e1a42748888/luaf156f3.jpg

相似文献

1
Extending the Graves' Triad: Thyroid Eye Disease, Dermopathy, and Acropachy: A Clinical Response to Teprotumumab.扩展格雷夫斯三联征:甲状腺眼病、皮肤病变和杵状指:对替普罗单抗的临床反应
JCEM Case Rep. 2025 Aug 13;3(9):luaf156. doi: 10.1210/jcemcr/luaf156. eCollection 2025 Sep.
2
Resolution of Thyroid Acropachy in a Patient Treated With Teprotumumab: A Case Report and Review of Mechanisms.用替普罗单抗治疗的患者甲状腺性杵状指的消退:病例报告及机制综述
Case Rep Endocrinol. 2025 Jul 18;2025:5544869. doi: 10.1155/crie/5544869. eCollection 2025.
3
Thyroid surgery for Graves' disease and Graves' ophthalmopathy.用于治疗格雷夫斯病和格雷夫斯眼病的甲状腺手术。
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD010576. doi: 10.1002/14651858.CD010576.pub2.
4
Long-Term Efficacy of Teprotumumab in Thyroid Eye Disease: Follow-Up Outcomes in Three Clinical Trials.甲状腺眼病中特罗特单抗的长期疗效:三项临床试验的随访结果。
Thyroid. 2024 Jul;34(7):880-889. doi: 10.1089/thy.2023.0656. Epub 2024 Jun 2.
5
Graves' disease thyroid dermopathy: a case report.格雷夫斯病甲状腺皮肤病:一例报告。
J Med Case Rep. 2024 Apr 7;18(1):164. doi: 10.1186/s13256-024-04462-x.
6
Radioiodine therapy versus antithyroid medications for Graves' disease.放射性碘治疗与抗甲状腺药物治疗Graves病的比较。
Cochrane Database Syst Rev. 2016 Feb 18;2(2):CD010094. doi: 10.1002/14651858.CD010094.pub2.
7
Rituximab for thyroid-associated ophthalmopathy.利妥昔单抗治疗甲状腺相关眼病。
Cochrane Database Syst Rev. 2022 Jun 16;6(6):CD009226. doi: 10.1002/14651858.CD009226.pub3.
8
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
9
Relation between therapy options for Graves' disease and the course of Graves' ophthalmopathy: a systematic review and meta-analysis.格雷夫斯病治疗方案与格雷夫斯眼病病程的关系:一项系统评价和荟萃分析。
J Endocrinol Invest. 2016 Nov;39(11):1225-1233. doi: 10.1007/s40618-016-0484-y. Epub 2016 May 24.
10
Steatotic liver disease arising in an asymptomatic 20-year-old man with panhypopituitarism and elevated transaminases.一名20岁无症状男性,患有全垂体功能减退症且转氨酶升高,出现了脂肪性肝病。
Can Liver J. 2024 Dec 19;7(4):511-516. doi: 10.3138/canlivj-2024-0030. eCollection 2024 Dec.

本文引用的文献

1
Thyroid dermopathy and thyroid eye disease associated with hypofunctional autoimmune thyroid disease with high TSI/anti-TSHR antibodies improved with teprotumumab.与高TSI/抗TSHR抗体的功能减退性自身免疫性甲状腺疾病相关的甲状腺皮肤病和甲状腺眼病经替普罗单抗治疗后有所改善。
BMJ Case Rep. 2024 Dec 22;17(12):e260129. doi: 10.1136/bcr-2024-260129.
2
Thyroid dermopathy responds to teprotumumab therapy.甲状腺皮肤病对替普罗图单抗治疗有反应。
Endocrinol Diabetes Metab Case Rep. 2022 Mar 1;2022. doi: 10.1530/EDM-21-0201.
3
Thyrotropin, Hyperthyroidism, and Bone Mass.
促甲状腺激素、甲状腺功能亢进症和骨量。
J Clin Endocrinol Metab. 2021 Nov 19;106(12):e4809-e4821. doi: 10.1210/clinem/dgab548.
4
Teprotumumab for the Treatment of Active Thyroid Eye Disease.特罗特鲁单抗治疗活动性甲状腺眼病。
N Engl J Med. 2020 Jan 23;382(4):341-352. doi: 10.1056/NEJMoa1910434.
5
Serial TSH-receptor antibody levels to guide the management of thyroid eye disease: the impact of smoking, immunosuppression, radio-iodine, and thyroidectomy.促甲状腺素受体抗体水平与甲状腺眼病管理:吸烟、免疫抑制、放射性碘和甲状腺切除术的影响。
Eye (Lond). 2019 Feb;33(2):212-217. doi: 10.1038/s41433-018-0242-9. Epub 2018 Nov 6.
6
Hypoxia-Dependent HIF-1 Activation Impacts on Tissue Remodeling in Graves' Ophthalmopathy-Implications for Smoking.缺氧依赖性HIF-1激活对格雷夫斯眼病组织重塑的影响——吸烟的意义
J Clin Endocrinol Metab. 2016 Dec;101(12):4834-4842. doi: 10.1210/jc.2016-1279. Epub 2016 Sep 9.
7
Cigarette Smoke Extract-Induced Oxidative Stress and Fibrosis-Related Genes Expression in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy.香烟烟雾提取物诱导的Graves眼病患者眼眶成纤维细胞氧化应激及纤维化相关基因表达
Oxid Med Cell Longev. 2016;2016:4676289. doi: 10.1155/2016/4676289. Epub 2016 Jun 2.
8
Smoking induces overexpression of immediate early genes in active Graves' ophthalmopathy.吸烟会导致活动性格雷夫斯眼病中即刻早期基因的过度表达。
Thyroid. 2014 Oct;24(10):1524-32. doi: 10.1089/thy.2014.0153. Epub 2014 Sep 19.
9
Extrathyroidal manifestations of Graves' disease: a 2014 update.格雷夫斯病的甲状腺外表现:2014年更新
J Endocrinol Invest. 2014 Aug;37(8):691-700. doi: 10.1007/s40618-014-0097-2. Epub 2014 Jun 10.
10
β-Arrestin-1 mediates thyrotropin-enhanced osteoblast differentiation.β-抑制蛋白-1介导促甲状腺素增强的成骨细胞分化。
FASEB J. 2014 Aug;28(8):3446-55. doi: 10.1096/fj.14-251124. Epub 2014 Apr 10.